Form D · Private Equity Fund

Aegis Special Situations QP Fund LLC - Series Medtech VIII

New York, NY · CIK 0001928800

Offering snapshot reported May 13, 2022 · SEC filing

Reported sold: $1.7M
Investors reported: 18
Minimum accepted: $0
First sale: Apr 29, 2022

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 13, 2022	Initial	$1,695,000	No comparison	18	SEC filing

Offering details

Securities: Equity, Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $59.8K
Finders' fees: $0
Form D file number: 021-445685

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Aegis Capital Corp.	15007

Source: Form D, filed May 13, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH VIII

Investment adviser: AEGIS CAPITAL CORP.

Gross asset value: $3.79M
Beneficial owners: 25
ADV minimum commitment: $100K

Reported in Form ADV on Aug 25, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator RELIANT FUND SERVICES, LLC NEW YORK, New York, United States Investor statements: No (provided to no investors) Related to adviser: No

Auditor CITRIN COOPERMAN & COMPANY, LLP NEW YORK, New York, United States

Custodian AXOS CLEARING LLC OMAHA, Nebraska, United States Related to adviser: No

Custodian INGALLS & SNYDER LLC NEW YORK, New York, United States Related to adviser: No

Custodian KINGDOM TRUST COMPANY MURRAY, Kentucky, United States Related to adviser: No

Custodian RBC CAPITAL MARKETS, LLC MINNEAPOLIS, Minnesota, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

CITRIN COOPERMAN & COMPANY, LLP
PCAOB 2468

AXOS CLEARING LLC
SEC 8-53595

RBC CAPITAL MARKETS, LLC
SEC 8-45411

Filing source

Form ADV 2128090 · Aug 25, 2026 · Schedule D 7.B.(1), fund 805-3870175900

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
Aegis Special Situations QP Fund LLC - Series Medtech IV	Mar 10, 2022	$2,557,500	12
Aegis Special Situations QP Fund LLC - Series Medtech VI	Feb 9, 2024	$827,750	13
Aegis Special Situations QP Fund LLC - Series Medtech VIII (this fund)	May 13, 2022	$1,695,000	18
Aegis Special Situations QP Fund, LLC - Series Medtech XIII	Nov 3, 2023	$2,583,750	35

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Aegis Capital Corp.	Promoter
Aegis Capital Holding Corp.	Promoter
Aegis Special Situations Management Llc	Director
Cassel Shapiro	Director, Executive
Adam Stern	Director, Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

810 Seventh Avenue 18 Th Floor
New York, NY, 10019